rs2289086

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005235.3(ERBB4):​c.3135+63A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.377 in 1,174,814 control chromosomes in the GnomAD database, including 87,539 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 13431 hom., cov: 32)
Exomes 𝑓: 0.37 ( 74108 hom. )

Consequence

ERBB4
NM_005235.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.57

Publications

16 publications found
Variant links:
Genes affected
ERBB4 (HGNC:3432): (erb-b2 receptor tyrosine kinase 4) This gene is a member of the Tyr protein kinase family and the epidermal growth factor receptor subfamily. It encodes a single-pass type I membrane protein with multiple cysteine rich domains, a transmembrane domain, a tyrosine kinase domain, a phosphotidylinositol-3 kinase binding site and a PDZ domain binding motif. The protein binds to and is activated by neuregulins and other factors and induces a variety of cellular responses including mitogenesis and differentiation. Multiple proteolytic events allow for the release of a cytoplasmic fragment and an extracellular fragment. Mutations in this gene have been associated with cancer. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008]
ERBB4 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 19
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-211420378-T-C is Benign according to our data. Variant chr2-211420378-T-C is described in ClinVar as Benign. ClinVar VariationId is 1283533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.549 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERBB4NM_005235.3 linkc.3135+63A>G intron_variant Intron 25 of 27 ENST00000342788.9 NP_005226.1 Q15303-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERBB4ENST00000342788.9 linkc.3135+63A>G intron_variant Intron 25 of 27 1 NM_005235.3 ENSP00000342235.4 Q15303-1
ERBB4ENST00000436443.5 linkc.3135+63A>G intron_variant Intron 25 of 26 1 ENSP00000403204.1 Q15303-3
ERBB4ENST00000260943.11 linkc.3105+63A>G intron_variant Intron 25 of 26 5 ENSP00000260943.7 Q15303-4H3BLT0

Frequencies

GnomAD3 genomes
AF:
0.408
AC:
61945
AN:
151702
Hom.:
13395
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.541
Gnomad AMI
AF:
0.287
Gnomad AMR
AF:
0.399
Gnomad ASJ
AF:
0.289
Gnomad EAS
AF:
0.449
Gnomad SAS
AF:
0.566
Gnomad FIN
AF:
0.271
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.345
Gnomad OTH
AF:
0.386
GnomAD4 exome
AF:
0.373
AC:
381310
AN:
1022994
Hom.:
74108
AF XY:
0.379
AC XY:
198245
AN XY:
523538
show subpopulations
African (AFR)
AF:
0.547
AC:
13209
AN:
24140
American (AMR)
AF:
0.422
AC:
16431
AN:
38896
Ashkenazi Jewish (ASJ)
AF:
0.310
AC:
7127
AN:
22956
East Asian (EAS)
AF:
0.494
AC:
17165
AN:
34772
South Asian (SAS)
AF:
0.561
AC:
41340
AN:
73684
European-Finnish (FIN)
AF:
0.287
AC:
14242
AN:
49656
Middle Eastern (MID)
AF:
0.393
AC:
1376
AN:
3500
European-Non Finnish (NFE)
AF:
0.347
AC:
253602
AN:
730134
Other (OTH)
AF:
0.372
AC:
16818
AN:
45256
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
11789
23578
35367
47156
58945
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7090
14180
21270
28360
35450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.409
AC:
62045
AN:
151820
Hom.:
13431
Cov.:
32
AF XY:
0.409
AC XY:
30382
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.542
AC:
22460
AN:
41448
American (AMR)
AF:
0.399
AC:
6078
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.289
AC:
1001
AN:
3466
East Asian (EAS)
AF:
0.449
AC:
2310
AN:
5148
South Asian (SAS)
AF:
0.567
AC:
2736
AN:
4824
European-Finnish (FIN)
AF:
0.271
AC:
2866
AN:
10566
Middle Eastern (MID)
AF:
0.390
AC:
114
AN:
292
European-Non Finnish (NFE)
AF:
0.345
AC:
23402
AN:
67822
Other (OTH)
AF:
0.387
AC:
816
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1793
3586
5378
7171
8964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.372
Hom.:
4528
Bravo
AF:
0.421
Asia WGS
AF:
0.513
AC:
1781
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 11, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 68% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 63. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.042
DANN
Benign
0.55
PhyloP100
-1.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2289086; hg19: chr2-212285103; API